27/06/2025

Search Posts biosimilar Page 2

Celltrion Secures USFDA Nod for Allergic Asthma Biosimilar

Celltrion Secures USFDA Nod for Allergic Asthma Biosimilar

March 10, 2025

Celltrion's Biosimilars for Bone Disorders Gain US Approval

Celltrion's Biosimilars for Bone Disorders Gain US Approval

March 4, 2025

Regulatory Violations in India’s Pharma Sector Decreased by 11% in 2024

Regulatory Violations in India’s Pharma Sector Decreased by 11% in 2024

February 27, 2025

Celltrion's Biosimilar for Autoimmune Disease Gains EC Approval

Celltrion's Biosimilar for Autoimmune Disease Gains EC Approval

February 24, 2025

India's Pharmaceutical Exports Could Hit $350 Billion by 2047: Study

India's Pharmaceutical Exports Could Hit $350 Billion by 2047: Study

February 9, 2025

Celltrion Secures FDA Approval for New Autoimmune Disease Biosimilar

Celltrion Secures FDA Approval for New Autoimmune Disease Biosimilar

January 31, 2025

Celltrion's Treatment for Autoimmune Diseases Launched in Five Key European Markets

Celltrion's Treatment for Autoimmune Diseases Launched in Five Key European Markets

January 23, 2025

Indian Pharmaceutical Firms Poised for Enhanced Growth in the US Market by 2025: HSBC

Indian Pharmaceutical Firms Poised for Enhanced Growth in the US Market by 2025: HSBC

December 11, 2024

Celltrion Secures Approval for Biosimilar Allergic Asthma Treatment in Canada

Celltrion Secures Approval for Biosimilar Allergic Asthma Treatment in Canada

December 9, 2024

South Korea Sees 22.5% Surge in Bio-Health Exports for Q3

South Korea Sees 22.5% Surge in Bio-Health Exports for Q3

November 29, 2024

1
2